Research Articles Library

Search tips: Keywords PMID Journal DOI or use Advanced Search for precise filtering
Literature Analysis Tools
Advanced Search

Filter by PMID, year, source, DOI and other criteria

Literature Analysis

Analyze research trends and hotspots

Batch Export

Export search results to Excel/PDF

How to Approach the Difficult Perineum in Crohn's Disease

Publication Year: 2024 Source: Clin Colon Rectal Surg PMID: 39944307

No Abstract

Artificial intelligence-enabled advanced endoscopic imaging to assess deep healing in inflammatory bowel disease

Publication Year: 2024 Source: eGastroenterology PMID: 39944363 DOI: 10.1136/egastro-2024-100090

Endoscopic remission is the primary long-term therapeutic goal in inflammatory bowel disease (IBD). The assessment of this therapeutic target typically relies on white light endoscopy (WLE) combined with histological sampling. Nonetheless, distinguishing between endoscopic mild, patchy inflammation and quiescent disease can be challenging, and discrepancies have been observed between endoscopic …

To explore the causal association between the serum lipid profile and inflammatory bowel disease using bidirectional Mendelian randomisation analysis

Publication Year: 2024 Source: eGastroenterology PMID: 39944468 DOI: 10.1136/egastro-2023-100034

BACKGROUND: Despite studies confirming that patients with inflammatory bowel disease (IBD) present with dyslipidaemia, the associations between IBD and the serum lipid profile have not been determined. The present study aimed to investigate the causal relationship between the serum lipid profile and IBD risk and elucidate the nature of the …

Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence

Publication Year: 2024 Source: eGastroenterology PMID: 39944472 DOI: 10.1136/egastro-2023-100055

Inflammatory bowel disease (IBD) is characterised by chronic inflammation in the gastrointestinal tract, with unclear aetiology but with known factors contributing to the disease, including genetics, immune responses, environmental factors and dysbiosis of the gut microbiota. Existing pharmacotherapies mainly target the inflammatory symptoms of disease, but recent research has highlighted …

Reproductive and sexual health concerns in gastrointestinal illness: a narrative review

Publication Year: 2024 Source: Transl Gastroenterol Hepatol PMID: 39944576 DOI: 10.21037/tgh-24-38

BACKGROUND AND OBJECTIVE: Gastrointestinal (GI) disorders, including inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), can have a profound and widespread impact on quality of life, including on reproductive and sexual functioning. However, reproductive and sexual concerns are rarely addressed in GI appointments and patients desire more information and …

Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: advances and future directions

Publication Year: 2024 Source: eGastroenterology PMID: 39944752 DOI: 10.1136/egastro-2023-100006

The pathogenesis of inflammatory bowel disease (IBD) is complex and multifactorial. Undertreated disease has substantial individual and societal consequences. Current patient classification and subsequent positioning of IBD therapy are based on crude, readily accessible clinical data. These broad parameters are unlikely to reflect underlying molecular profiles and may account for …

A Comparison of Intravenous Infliximab Versus Subcutaneous Infliximab on Remission Rates, Safety, Costs, Patient Preferences in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Publication Year: 2024 Source: Gastro Hep Adv PMID: 39944928 DOI: 10.1016/j.gastha.2024.11.004

BACKGROUND AND AIMS: Infliximab, widely used as a mainstay treatment of inflammatory bowel disease (IBD), is traditionally administered intravenously. The subcutaneous (SC) formulation appears to offer a more convenient route of administration. This is a systematic review and meta-analysis comparing the outcomes of intravenous (IV) and SC routes of administration …

[A Case of Lynch Syndrome Diagnosed with MSI-H Ulcerative Colitis-Associated Colon Cancer]

Publication Year: 2024 Source: Gan To Kagaku Ryoho PMID: 39948952

No Abstract

Fetal and Early-Life Antibiotics and Risk of Pediatric Inflammatory Bowel Disease: A Population-Based Nationwide Register Study

Publication Year: 2024 Source: J Pediatr Clin Pract PMID: 39949419 DOI: 10.1016/j.jpedcp.2024.200096

OBJECTIVE: To assess whether antibiotic exposure prenatally and before 2 years of age is associated with subsequent pediatric inflammatory bowel disease (PIBD), as earlier studies diverge substantially in risk estimations or do not include prenatal exposure. METHODS: We performed a register-based cohort study including all children in Norway born 2004-2012 …

Persistence of newly prescribed 5-aminosalicylic acid in patients with ulcerative colitis: A nationwide comprehensive database study

Publication Year: 2024 Source: PLoS One PMID: 39775682

No Abstract

98453 Results
Page of
9846 Pages
Need more literature?

The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.

Knowledge Acquisition Module: Upload and analyze your own literature files
External Resources: Access comprehensive literature databases worldwide